Sarah Romano Kiora Pharmaceuticals Inc (KPRX) insider trading activity

Sarah Romano is Chief Financial Officer of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 22,746 shares of KPRX, which is worth approximately $74,379. The most recent transaction as insider was on Feb 10, 2022, when has been sold 108 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $75. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.7K

0% 3M change

0% 12M change

Total Value Held $74,379

Sarah Romano Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2022	SELL Payment of exercise price or tax liability	$75 $0.69 p/Share	108 Reduced 0.47%	22,746 Common Stock
Jan 05 2022	SELL Payment of exercise price or tax liability	$123 $1.08 p/Share	114 Reduced 0.5%	22,854 Common Stock
Dec 07 2021	SELL Payment of exercise price or tax liability	$118 $1.3 p/Share	91 Reduced 0.39%	22,968 Common Stock
Nov 02 2021	SELL Payment of exercise price or tax liability	$164 $1.98 p/Share	83 Reduced 0.36%	23,059 Common Stock
Oct 04 2021	SELL Payment of exercise price or tax liability	$167 $2.01 p/Share	83 Reduced 0.36%	23,142 Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$152 $1.81 p/Share	84 Reduced 0.36%	23,225 Common Stock
Aug 03 2021	SELL Payment of exercise price or tax liability	$209 $2.4 p/Share	87 Reduced 0.37%	23,309 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	$666 $3.7 p/Share	180 Reduced 0.76%	23,396 Common Stock
Jun 04 2021	SELL Payment of exercise price or tax liability	$754 $4.19 p/Share	180 Reduced 0.76%	23,576 Common Stock
May 04 2021	SELL Payment of exercise price or tax liability	$731 $4.13 p/Share	177 Reduced 0.74%	23,756 Common Stock
Apr 08 2021	SELL Payment of exercise price or tax liability	$889 $4.94 p/Share	180 Reduced 0.75%	23,933 Common Stock
Mar 03 2021	SELL Payment of exercise price or tax liability	$1,190 $5.46 p/Share	218 Reduced 0.9%	24,113 Common Stock
Feb 02 2021	SELL Payment of exercise price or tax liability	$8,128 $6.34 p/Share	1,282 Reduced 5.01%	24,331 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$558 $4.85 p/Share	115 Reduced 0.45%	25,613 Common Stock
Dec 07 2020	SELL Payment of exercise price or tax liability	$342 $3.76 p/Share	91 Reduced 0.35%	25,728 Common Stock
Nov 02 2020	SELL Payment of exercise price or tax liability	$340 $3.51 p/Share	97 Reduced 0.37%	25,819 Common Stock
Oct 02 2020	SELL Payment of exercise price or tax liability	$380 $3.88 p/Share	98 Reduced 0.38%	25,916 Common Stock

Also insider at

FWBI

First Wave BioPharma, Inc. Healthcare

Chief Financial Officer

Sarah Romano

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX

Account